The present invention is concerned with pharmaceutical compositions comprising a mixture of amlodipine enantiomers, which compositions have both anti-hypertensive and additional cardiovascular properties derived respectively from their calcium channel-blocking activity and their ability to release vascular nitric oxide (NO).
CROSS-REFERENCE TO RELATED APPLICATIONS
The present application is a U.S. non-provisional application. This application claims the benefit of U.S. Ser. No. 60/237,168, filed on Oct. 2, 2000, under 35 USC 119(e).
